Clinical Trial Update: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aminolevulinic acid (5-ALA) for fluorescence-guided visualization of glioblastoma tumors during surgical resection in adults; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Michael Vogelbaum, MD, PhD | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2018-07-31